Special Issue "The Prevention, Treatment, and Complications of Diabetes Mellitus"

Ana I Arroba^{1

2}, Manuel Aguilar-Diosdado^{1

2

3}

Affiliations

¹ Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11009 Cádiz, Spain.
² Department of Endocrinology and Metabolism, Hospital Puerta del Mar, 11009 Cádiz, Spain.
³ School of Medicine, Cadiz University (UCA), Ana de Viya 21, 11009 Cadiz, Spain.

Editorial

Ana I Arroba et al. J Clin Med. 2022.

. 2022 Sep 9;11(18):5305.

doi: 10.3390/jcm11185305.

Ana I Arroba^{1

2}, Manuel Aguilar-Diosdado^{1

2

3}

¹ Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11009 Cádiz, Spain.
² Department of Endocrinology and Metabolism, Hospital Puerta del Mar, 11009 Cádiz, Spain.
³ School of Medicine, Cadiz University (UCA), Ana de Viya 21, 11009 Cadiz, Spain.

Abstract

Diabetes mellitus (DM) is a world health problem of global repercussion [...].

The authors declare no conflict of interest.

1. IDF Diabetes Atlas 2022 International Diabetes Federation. [(accessed on 21 August 2022)]. Available online: https://diabetesatlas.org/
1. Gillespie K.M. Type 1 diabetes: Pathogenesis and prevention. Can. Med. Assoc. J. 2006;175:165–170. doi: 10.1503/cmaj.060244. - DOI - PMC - PubMed
1. DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus. Med. Clin. N. Am. 2004;88:787–835. doi: 10.1016/j.mcna.2004.04.013. - DOI - PubMed
1. Diedisheim M., Carcarino E., Vandiedonck C., Roussel R., Gautier J.-F., Venteclef N. Regulation of inflammation in diabetes: From genetics to epigenomics evidence. Mol. Metab. 2020;41:101041. doi: 10.1016/j.molmet.2020.101041. - DOI - PMC - PubMed
1. Nathan D.M., DCCT/EDIC Research Group The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care. 2014;37:9–16. doi: 10.2337/dc13-2112. - DOI - PMC - PubMed